HOME >> BIOLOGY >> NEWS
Fox Chase Cancer Center study: Novel DNA-repair gene mutation can cause resistance to cancer drugs

In a paper to be published in the Nov. 25 issue of Proceedings of the National Academy of Sciences, the laboratory of cancer geneticist Alfonso Bellacosa, M.D., of Fox Chase Cancer Center reports new findings linking a novel genetic mutation to the ability of human cancers to resist certain anticancer drugs. The paper, entitled "The Base Excision Repair Enzyme MED1 Mediates DNA Damage Response to Anti-Tumor Drugs and Is Associated with Mismatch Repair System Integrity," will first appear in the PNAS Online Early Edition (www.pnas.org) the week of Nov. 10-14.

Bellacosa's group previously had found the defective gene Med1 to be associated with nonpolyposis colorectal tumors, the most common form of hereditary colorectal cancer (Nature Genetics, November 1999). This gene's protein product, MED1, is an enzyme that normally helps cells repair potentially cancer-causing damage to genes, both directly and indirectly.

"Ironically, the defective MED1 enzyme not only might prevent repairs in normal cells and permit a cancer to start, but in particular, the enzyme also interferes with the effectiveness of some types of chemotherapy," said Bellacosa. The result is a cancer that resists certain widely used drugs, such as 5-fluorouracil (5-FU) and oxaliplatin, a major drug combination used to treat patients with colorectal cancer.

The normal version of the enzyme helps repair DNA damage in two ways. In one repair activity, the enzyme acts like a scissors to remove an altered DNA base in a system called base-excision repair. The enzyme also interacts with another protein in the mismatch-repair system. This system recognizes mismatched DNA bases during a cell's reproductive cycle, when a cell divides and must duplicate its DNA. Ideally, the two strands of DNA's double helix fit together like a zipper. If a duplicated pair of DNA bases forms a mismatch that cannot bond properly, the mismatch-repair system attempts to repair t
'"/>

Contact: Karen Carter Mallet
k_carter@fccc.edu
215-728-2700
Fox Chase Cancer Center
10-Nov-2003


Page: 1 2

Related biology news :

1. Fox Chase Cancer Centers Alfred Knudson Jr. named 2004 Kyoto Prize winner
2. Fox Chase discovery may help physicians diagnose, treat devastating childhood disease
3. Wilex & Fox Chase Cancer Center begin trial w/ novel compound targeting tumor invasion & metastasis
4. Fox Chase Cancer Center research shows kidney cancer can be diagnosed in urine
5. Fox Chase Cancer Center researchers identify significant smoking-induced genetic alteration
6. Fox Chase Cancer Center research reveals how COX-2 causes ovarian cancer
7. Fox Chase Cancer Center research shows kidney cancer can be diagnosed in urine
8. Fox Chase Cancer Center researcher develops new model for studying prions mad cow disease
9. NIH funds Breast Cancer and the Environmental Research Center at Fox Chase Cancer Center
10. Fox Chase Cancer Center researchers make significant discovery about function of p53
11. Fox Chase Cancer Center receives grant to study possible link between measles vaccine and autism

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/3/2020)... , ... August 03, 2020 , ... ... announced a new partnership with medical equipment manufacturer, Spectrum Solutions, to provide COVID-19 ... to strengthen their laboratory supply chain for more than 10 years. Early in ...
(Date:7/18/2020)... ... 16, 2020 , ... A study has been published in ... active noise control device to attenuate typical noises in a simulated neonatal intensive ... alarm sounds from patient monitors, ventilators and other bedside devices that would affect ...
(Date:7/4/2020)... ... 2020 , ... Aesthetics Biomedical (ABM), a leading aesthetics product ... only the products and treatments developed, but also the dedicated team behind the ... brands built by ABM have received several honors already for 2020, each of ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... ... August 11, 2020 , ... Modality ... for free its new white paper – Simulated Transport Methodologies. Regulatory expectations ... biologics licensing application (BLA). In response, Modality Solutions shares an explanation of ...
(Date:8/3/2020)... ... August 03, 2020 , ... Introducing Ardent Animal Health – MediVet Biologics rebrands ... , Known as MediVet Biologics since its formation in 2016, the company is ... Animal Health will build on its base of innovative therapies for osteoarthritis and cancer. ...
(Date:7/31/2020)... ... July 29, 2020 , ... Anomet Products has introduced ... materials for use with CRM, neurostimulation, vascular, and related devices. , Anomet ... design requirements, performance, and cost criteria; especially where solid wire is limited. Typical ...
(Date:7/31/2020)... ... July 30, 2020 , ... ... today announced the release of its signature product called Beacon - a ... and other field medical professionals. , Beacon helps MSLs streamline communication ...
Breaking Biology Technology:
Cached News: